uniQure (QURE) Total Current Liabilities (2015 - 2026)
uniQure (QURE) recorded quarterly Total Current Liabilities of $59.2 million in Q1 2026, down 5.92% quarter-over-quarter from $62.9 million in Q4 2025, and up 63.03% on a YoY basis from $36.3 million in Q1 2025.
uniQure (QURE) Total Current Liabilities (2015 - 2026) Analysis & Trends
uniQure's Total Current Liabilities history runs 12 years deep, the most recent figure standing at $59.2 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 63.03% year-over-year to $59.2 million; the TTM figure through Mar 2026 stood at $59.2 million (up 63.03% YoY), while the FY2025 annual figure was $62.9 million, up 57.09% from the prior year.
- Total Current Liabilities was $59.2 million for Q1 2026 at uniQure, down from $62.9 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $100.6 million in Q3 2025 to a low of $36.3 million in Q1 2025.
- Historically, Total Current Liabilities has averaged $62.7 million across 5 years, with a median of $64.0 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities surged 106.51% in 2022, then slumped 49.14% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $75.9 million in 2022, then fell by 2.96% to $73.7 million in 2023, then slumped by 45.64% to $40.1 million in 2024, then surged by 57.09% to $62.9 million in 2025, then retreated by 5.92% to $59.2 million in 2026.
- The last three Total Current Liabilities figures came in at $59.2 million (Q1 2026), $62.9 million (Q4 2025), and $100.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 59.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.20 Mn |
| Dec 31, 2025 | 62.92 Mn |
| Sep 30, 2025 | 100.63 Mn |
| Jun 30, 2025 | 40.93 Mn |
| Mar 31, 2025 | 36.31 Mn |
| Dec 31, 2024 | 40.05 Mn |
| Sep 30, 2024 | 71.27 Mn |
| Jun 30, 2024 | 80.47 Mn |
| Mar 31, 2024 | 63.47 Mn |
| Dec 31, 2023 | 73.68 Mn |
| Sep 30, 2023 | 68.61 Mn |
| Jun 30, 2023 | 68.36 Mn |
| Mar 31, 2023 | 66.34 Mn |
| Dec 31, 2022 | 75.92 Mn |
| Sep 30, 2022 | 63.97 Mn |
| Jun 30, 2022 | 48.26 Mn |
| Mar 31, 2022 | 44.70 Mn |
| Dec 31, 2021 | 36.76 Mn |
| Sep 30, 2021 | 41.92 Mn |
| Jun 30, 2021 | 46.10 Mn |